/PRNewswire/ A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled.
/PRNewswire/ The "Liposomal Doxorubicin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to.
Overview of Global Microscopic Polyangiitis Market:An international Microscopic Polyangiitis Market report covers a Market overview and the growth prospects of the Market. The current environment of the Healthcare industry and the key trends determining the Market are presented in the report. The Market report is a.
Investegate |PAION AG Announcements | PAION AG: PAION GRANTS EXCLUSIVE LICENSE TO TTY BIOPHARM FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN TAIWAN investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Taiwan recalls cancer drugs containing extraneous material
01/19/2021 03:45 PM
A TTY Biopharm production line. CNA file photo
Taipei, Jan. 19 (CNA) A total of 9,000 cancer drugs manufactured by the Taiwanese company TTY Biopharm Company Limited are being recalled because they were found to contain extraneous material, Taiwan s Food and Drug Administration (FDA) said Tuesday.
The drugs include Gemmis injection 38 mg/ml, which is usually used in combination with other medicines such as Gemcitabine and paclitaxel to treat cancer of the lungs, pancreas, bladder and breast in specific cases, the FDA said.
The contamination of the 9,000 cancer drugs with extraneous material was discovered after a hospital reported such findings to the FDA in December 2020, said Hung Kuo-teng (洪國登), head of the FDA s Medicinal Products Division.